Showing results (191-200 of 337) with videos related to
Sort By:
Pageof 34
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2022
Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 PandemicThao Doan, Fabio Lievano, Linda Scarazzini, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 30, 2018
Edoxaban for Venous Thromboembolism Treatment-The New Kid on The Block for Latin America. A Practical GuideEduardo Ramacciotti, Valéria Cristina Resende Aguiar, Valter Castelli Júnior, et al.Expert Opinion on Investigational Drugs|February 28, 2002
Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agentJeanine M Walenga, Walter P Jeske, M Michel Samama, et al.Blood|March 6, 2002
Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosisVijay V Kakkar, Debra A Hoppenstead, Jawed Fareed, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 8, 2009
The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activityCinara L Echart, Barbara Graziadio, Simona Somaini, et al.Seminars in Thrombosis and Hemostasis|April 9, 2008
Survival of heparins, oral anticoagulants, and aspirin after the year 2010Jawed Fareed, Debra A Hoppensteadt, Daniel Fareed, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2019
Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment ValuesFakiha Siddiqui, Alfonso Tafur, Lorenzo Storino Ramacciotti, et al.Analytical Chemistry|July 21, 2015
Differentiation of generic enoxaparins marketed in the United States by employing NMR and multivariate analysisMarco Guerrini, Timothy R Rudd, Lucio Mauri, et al.Seminars in Thrombosis and Hemostasis|January 5, 2005
Generic low-molecular-weight heparins: some practical considerationsJawed Fareed, Wendy L Leong, Debra A Hoppensteadt, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 12, 2022
Arterial-renal Syndrome in Patients with ESRD, a New Disease ParadigmJake Goldstein, Robert S Dieter, Vinod Bansal, et al.Pageof 34